Search
for
Sort by
Research 61–90 of 1000+
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Clinical positioning and future prospects of JAK inhibitors in alopecia areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- A novel therapeutic paradigm for patients with extensive alopecia areata
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Treating Alopecia Areata: Current Practices Versus New Directions
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Mechanisms of autophagy and their implications in dermatological disorders
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Tofacitinib citrate alleviates alopecia universalis symptoms in recent case study
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Immune Regulation in Hair Follicle Protection and Hair Regeneration: Insights from the Collapse of Immune Privilege in Alopecia Areata and Targeted Immunotherapy
- Alopecia areata
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo